drugset / Trial / NCT06366243
A Trial to Evaluate the Effect of Esomeprazole on the Pharmacokinetics of Emraclidine in Healthy Adult Participants
NaSingle-groupOpen-labelTreatment
Summary
The primary purpose of this study is to evaluate the potential of gastric pH-dependent drug-drug interaction effect of esomeprazole, a proton pump inhibitor (PPI), on the pharmacokinetics (PK) of emraclidine in healthy adult participants.
Timeline
- Start
- 2024-05-10
- Primary completion
- 2024-06-20
- Completion
- 2024-06-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Emraclidine | Small molecule | 30 mg | Oral |
| Subject | Esomeprazole | Small molecule | 40 mg | Oral |
Indications
No indication recorded.